Providence’s Ximedica to Partner with Life Sciences Venture Capital Firm
Thursday, November 06, 2014
Ximedica - a FDA registered product development firm focused on medical technology - will be partnering with SV Life Sciences - a life sciences venture capital firm - to embark on a growth strategy for products in the biotechnology and medical technology fields.
"We are excited to partner with SV Life Sciences as we embark upon the next phase of our global growth strategy," said Ximedica CEO Randall Barko. "Their experience in working with entrepeneurs and management teams in the Americas and Europe [and] deep medtech expertise and industry relationships [...] will be important as we take advantage of opportunities in expanding markets."
SV's COO and Managing Partner Paul LaViolette will join Barko and Ximedica's CIO Aidan Petrie as Chairman of Ximedica's board.
GET THE LATEST BREAKING NEWS HERE -- SIGN UP FOR GOLOCAL FREE DAILY EBLASTXimedica will maintain its Providence-based status, by keeping headquarters in the city.
Ximedica is located at 55 Dupont Dr., Providence, RI.
Related Articles
- RI to Host Groundbreaking Medical Trial for C. Diff
- Onsite Medical Clinics: Battling Rising Healthcare Costs
- Patient Centered Medical Homes: A Health Care Revolution Worth Supporting
- Fuel, Feed, and Heal the World Through Biotechnology
- The Importance of Biotechnology for You and the World
- RI Schools Receive $20 Million Marine Life Science Research Grant
- NEW: RI Life Science Companies Strut Their Stuff
